FDA Inspection
Hangzhou Zhongmei Huadong Pharmaceutical Co., LtdHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd – FDA Inspection, Feb 28, 2017
Record Details
This FDA Inspection record concerns Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, with an inspection on February 28, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- February 28, 2017
- Product Type
- Human Drugs
- People
- Christopher T. Middendorf (FDA Associated Person)
- Ruo H. Xu (Issuing Officer)
View Company Profile
ID · 8b4570f4-eaa4-4af8-be95-ca53405beea5
Inspection Facts
- Inspection number
- 1006423
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | Office of Inspections and Investigations | |
| August 18, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 2, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
- FDA Inspection 1341100 - 2026-09-18
- FDA Inspection 1217084 - 2023-08-18
- FDA Inspection 1064409 - 2018-08-23
- FDA Inspection 985170 - 2016-07-28
- FDA Inspection 880928 - 2014-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.